TELA Bio (TELA) to Release Earnings on Thursday

TELA Bio (NASDAQ:TELA - Get Free Report) is expected to announce its earnings results after the market closes on Thursday, March 20th. Analysts expect the company to announce earnings of ($0.24) per share and revenue of $23.17 million for the quarter. Investors interested in participating in the company's conference call can do so using this link.

TELA Bio Trading Up 4.9 %

Shares of NASDAQ TELA traded up $0.11 during midday trading on Friday, hitting $2.35. The stock had a trading volume of 119,861 shares, compared to its average volume of 156,183. The company has a debt-to-equity ratio of 14.22, a current ratio of 2.62 and a quick ratio of 1.81. TELA Bio has a fifty-two week low of $2.18 and a fifty-two week high of $6.50. The firm has a market cap of $92.56 million, a P/E ratio of -1.39 and a beta of 1.10. The company's 50-day simple moving average is $2.62 and its 200 day simple moving average is $2.73.

TELA Bio Company Profile

TELA Bio, Inc, a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene fiber intended to be used in laparoscopic and robotic-assisted hernia surgical repairs.